🔎 Trials Near Me

Gara Jalqabaatti › Sukkaraa Gosa 2

Qorannoo klinikaalii Sukkaraa Gosa 2 Ameerikaa Keessatti hirmaatuu

Qorannoo 240 Sukkaraa Gosa 2 f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06706284

Integrating New Skills Into Diabetes Education With CGM

Namoota walitti qabaa jira
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07463209

SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 14 hanga 24 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07409714

The RESET System Pivotal Clinical Trial (Protocol Revision H)

Namoota walitti qabaa jira
Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04101669

Efficacy of Using Mobile Health Applications for Health

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05589155

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05279729

Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

Namoota walitti qabaa jira
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07641361

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06906640

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07754461

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07817251

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

Namoota walitti qabaa jira
Umuriin 18 fi ol · Dubartoota · Haaromfame 29-Ful-2026 · NCT05909046

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06593327

A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07223333

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07595549

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07399678

Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06836479

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06112418

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

Namoota walitti qabaa jira
Umuriin 8 hanga 21 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05463289

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.